The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome

Figure 2

Chest X-rays of patients II, IV, and VII before (A) and after (B) treatment with dornase alfa. Imaging demonstrates improved resolution of opacities including for those who had prolonged mechanical ventilation (patients II, P2A/B, and VII, P7A/B) and for those not requiring mechanical ventilation (patient IV, P4A/B).